Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine for cardiac function in children with subclinical hypothyroidism
IRCT20180228038900N3Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levothyroxine sodium in hypothyroidism, sponsored by Babol University of Medical Sciences. Primary endpoints: LVSD, LVDD and 4 more. Started Oct 2018; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on IRCT20180228038900N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180228038900N3.